Network analysis of microRNAs, genes and their regulation in human bladder cancer

Li,Yang; Xu,Zhiwen; Wang,Kunhao; Wang,Ning; Zhu,Minghui

doi:10.3892/br.2013.157

Network analysis of microRNAs, genes and their regulation in human bladder cancer

Authors:
- Yang Li
- Zhiwen Xu
- Kunhao Wang
- Ning Wang
- Minghui Zhu
View Affiliations

Affiliations: College of Computer Science and Technology, Jilin University, Changchun, Jilin 130012, P.R. China
Published online on: August 19, 2013 https://doi.org/10.3892/br.2013.157
Pages: 918-924

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Bladder cancer (BC) is the fifth most common malignancy occurring worldwide and a significant cause of cancer‑related morbidity and mortality. Although BC is a serious health issue, studies available concerning the relationship of genes, microRNAs (miRNAs) and their host genes has been lacking. In the present study, we assessed experimentally validated data from various sources that reported the effect of miRNA on various diseases, miRNA targeting of mRNAs, and combined these data with initial transcription factor (TF) binding site predictions within miRNA promoter regions. Topology networks obtained in this study included the differentially expressed, BC‑associated and global networks. The three networks may be used to assess the effect of miRNAs and their regulation in human BC. By comparing and analyzing the similarities and differences among the three networks, key nodes with the largest potential of affecting the behavior of a particular network were identified. The results also showed potentially substantially influential miRNAs and TFs, which revealed subnetworks demonstrating the mechanisms involved as well as regulatory miRNA network motifs in human BC. Regulatory pathways regarding differentially expressed elements, such as genes and miRNAs, demonstrate self‑adapting associations including, self‑adapting associations and feedback loops in genes MYC, TP53, PTEN and 10 differentially expressed miRNAs. The differentially expressed network partially identified the BC mechanism. miRNA‑targeted human BC genes were also enriched in highly relevant pathways, cell cycle regulation and apoptosis. The present study systematically delineated the pathogenesis of BC and provided theoretical foundations for gene therapy investigators to focu attention on key genes and miRNAs in future studies.

View Figures

View References

1	Jemal A, Murray T, Ward E, et al: Cancer statistics, 2005. CA Cancer J Clin. 55:10–30. 2005. View Article : Google Scholar
2	Pashos CL, Botteman MF, et al: Bladder cancer: epidemiology, diagnosis, and management. Cancer Pract. 10:311–322. 2002. View Article : Google Scholar : PubMed/NCBI
3	Wang DS, Rieger-Christ K, Latini JM, et al: Molecular analysis of PTEN and MXI1 in primary bladder carcinoma. Int J Cancer. 88:620–625. 2000. View Article : Google Scholar : PubMed/NCBI
4	Hobert O: Gene regulation by transcription factors and microRNAs. Science. 319:1785–1786. 2008. View Article : Google Scholar : PubMed/NCBI
5	Calin GA, Dumitru CD, Shimizu M, et al: Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 99:15524–15529. 2002. View Article : Google Scholar : PubMed/NCBI
6	Rodriguez A, Griffiths-Jones S, Ashurst JL and Bradley A: Identification of mammalian microRNA host genes and transcription units. Genome Res. 14:1902–1910. 2004. View Article : Google Scholar : PubMed/NCBI
7	Baskerville S and Bartel DP: Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA. 11:241–247. 2005. View Article : Google Scholar : PubMed/NCBI
8	Cao GJ, Huang BC, Liu ZH, et al: Intronic miR-301 feedback regulates its host gene, ska2, in A549 cells by targeting MEOX2 to affect ERK/CREB pathways. Biochem Biophys Res Commun. 396:978–982. 2010. View Article : Google Scholar : PubMed/NCBI
9	Sethupathy P, Corda B and Hatzigeorgiou AG: TarBase: a comprehensive database of experimentally supported animal microRNA targets. RNA. 12:192–197. 2006. View Article : Google Scholar : PubMed/NCBI
10	Hsu SD, Lin FM, Wu WY, et al: miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res. 39:D163–D169. 2011. View Article : Google Scholar : PubMed/NCBI
11	Wang J, Lu M, Qiu CX and Cui QH: TransmiR: a transcription factor-microRNA regulation database. Nucleic Acids Res. 38:D119–D122. 2010. View Article : Google Scholar : PubMed/NCBI
12	Griffiths-Jones S, Saini HK, van Dongen S and Enright AJ: miRBase: tools for microRNA genomics. Nucleic Acids Res. 36:D154–D158. 2008. View Article : Google Scholar : PubMed/NCBI
13	Kanehisa M, Goto S, Furumichi M, Tanabe M and Hirakawa M: KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 38:D355–D360. 2010. View Article : Google Scholar : PubMed/NCBI
14	Chekmenev DS, Haid C and Kel AE: P-Match: transcription factor binding site search by combining patterns and weight matrices. Nucleic Acids Res. 33:W432–W437. 2005. View Article : Google Scholar : PubMed/NCBI
15	Dreszer TR, Karolchik D, Zweig AS, et al: The UCSC Genome Browser database: extensions and updates 2011. Nucleic Acids Res. 40:D918–D923. 2012. View Article : Google Scholar : PubMed/NCBI
16	Kao A, Poteet SR, Jones DH, et al: P-MATCH: Identifying Part Name in Noisy Text Data. Cross-Disciplinary Advances in Applied Natural Language Processing: Issues and Approaches. Boonthum-Denecke C, McCarthy PM and Lamkin T: IGI Global; Hershey: pp. 172–184. 2011
17	Jiang QH, Wang YD, Hao YY, et al: miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res. 37:D98–D104. 2009. View Article : Google Scholar : PubMed/NCBI
18	Swallows DM, Gendler S, Gribths B, et al: The hypervariable gene locus PUM, which encodes for the tumour associated epithelial mucins, is located on chromosome 1, within the region 1q21–24. Ann Hum Genet. 51:289–294. 1987.PubMed/NCBI
19	Zotter S, Hageman PC, Lossnitzer A, Mooi WJ and Hilgers J: Tissue and tumour distribution of human polymorphicepithelial mucin. Cancer Rev. 11:55–79. 1988.
20	Girling A, Bartkova J, Burchell J, et al: A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas. Int J Cancer. 43:1072–1076. 1989. View Article : Google Scholar
21	Simms MS, Hughes ODM, Limb M, Price MR and Bishop MC: MUC1 mucin as a tumour marker in bladder cancer. BJU Int. 84:350–352. 1999. View Article : Google Scholar : PubMed/NCBI
22	Kompier LC, Lurkin I, van der Aa MN, van Rhijn BW, van der Kwast TH and Zwarthoff EC: FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy. PloS One. 5:e138212010. View Article : Google Scholar : PubMed/NCBI